Clinical Trials
12
Active:6
Completed:3
Trial Phases
2 Phases
Phase 1:8
Phase 2:4
Drug Approvals
2
EMA:2
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
8 (66.7%)Phase 2
4 (33.3%)Pharmacokinetics of Afamelanotide in EPP Patients
Phase 1
Completed
- Conditions
- Erythropoietic Protoporphyria
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Clinuvel Europe Limited
- Target Recruit Count
- 28
- Registration Number
- NCT06388642
- Locations
- 🇳🇱
CLINUVEL Site, Rotterdam, Netherlands
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Clinuvel Europe Limited
- Target Recruit Count
- 6
- Registration Number
- NCT05370235
- Locations
- 🇪🇸
CLINUVEL Investigational site, Clinuvel Investigational Site, Spain
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Clinuvel Europe Limited
- Target Recruit Count
- 6
- Registration Number
- NCT05159752
- Locations
- 🇩🇪
CLINUVEL investigative site, Regensburg, Germany
News
No news found